• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

First-degree family history of breast cancer associated with increased risk of breast cancer in older women

byShayna BejaimalandAnees Daud
February 23, 2018
in Chronic Disease, Endocrinology, Obstetrics, Public Health, Surgery
Reading Time: 3 mins read
Topical analgesia for dyspareunia effective in breast cancer survivors
Share on FacebookShare on Twitter

1. In this prospective cohort study, first-degree family history of breast cancer was associated with increased risk of breast cancer in women 65 years and older.

2. In women 65 to 74 years old, the risk was highest in those with fatty breasts whereas in women 75 years and older the risk was highest among those with dense breasts.

Evidence Rating Level: 2 (Good)

Study Rundown: While family history of a first-degree relative with breast cancer is a strong risk factor for breast cancer in younger women, it is unclear how influential this risk factor is for older women. This prospective cohort study aimed to determine whether first-degree family history is associated with increased risk of breast cancer among older women and to identify whether this association varies by breast density.

First-degree family history was associated with statistically significant increased risk of breast cancer in women 65 years and older. It did not matter whether the first-degree relative with breast cancer was younger or older than 50. For women 65 to 74 years old, risk associated with first-degree relative was highest in those with fatty breasts and in women 75 years and older the risk was highest among those with dense breasts. Strengths of this study included use of a large population-based sample with diverse socioeconomic and ethnic backgrounds. However, limitations included use of only first-degree relative information, as there is evidence that second-degree relatives with breast cancer may also confer increased risk.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

Historical redlining associated with lower breast cancer screening across urban neighborhoods

Breast cancer screening with MRI provides modest benefit for high-risk women

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

Relevant Reading: Family History, Mammographic Density, and Risk of Breast Cancer

In-Depth [prospective cohort]: This prospective cohort study was conducted between 1996 and 2012 using seven breast cancer registries from seven sites across the USA. These registries included women who presented for screening mammographies. The study’s sample consisted of 472,220 mammograms from 403,268 women 65 years and older who provided self-reported information about first-degree relative family history between 1996 and 2012. Women with a diagnosis of breast cancer prior to or within 3 months of eligible mammogram, or those with breast implants, mastectomy or without BI-RADS breast density were excluded. The exposure of interest was first-degree family of breast cancer and they were followed for a mean (SD) of 6.3 (3.2) years for the outcome of incident breast cancer. The 5-year cumulative incidence of invasive breast cancer by first-degree family history, breast density, and age groups were estimated. Cox proportional hazards models were fit to estimate the association of first-degree family history with risk of invasive breast cancer.

In the sample, first-degree family history was associated with an increased risk of breast cancer among women aged 65 and older: 65-74 years HR 1.48; 95% CI 1.35-1.61, 75 years and older HR 1.44; 95% CI 1.28-1.62. The age of the first degree relative upon diagnosis of breast cancer did not statistically alter risk of breast cancer in these women. However, among women 65 to 74 years old, the risk associated with first-degree relative family history was highest among women with fatty breasts (HR 1.67; 95% CI 1.27-2.21) whereas in women who were 75 years and older, the risk associated with first-degree relative family history was highest among those with dense breasts (HR 1.55; 95% CI 1.29-1.87).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: breast cancer screeningbreast cancer survival
Previous Post

Oral neonatal rotavirus vaccine RV3-BB effective in preventing severe gastroenteritis

Next Post

Firearm storage practices unrelated to childrens’ risk of self-harm

RelatedReports

Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Quick Take: Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis–free Survival
Oncology

Breast cancer screening with MRI provides modest benefit for high-risk women

March 2, 2026
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Chronic Disease

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

April 2, 2025
Next Post
AAP supports mindfulness of children’s media consumption

Firearm storage practices unrelated to childrens’ risk of self-harm

Corticosteroids improve outcomes in treatment of community-acquired pneumonia

Prophylactic haloperidol not linked to improved survival in ICU patients: The REDUCE trial

Talk therapy, modified for literacy level, helps ease chronic pain for disadvantaged populations

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.